Coagulase-negative staphylococcus.
Andriole VT, Lyons RW.
Ann N Y Acad Sci. 1970 Oct 30;174(2):533-44. doi: 10.1111/j.1749-6632.1970.tb45579.x.
Epidemiology and Pathogenesis of Staphylococcus Bloodstream Infections in Humans: a Review.
Lisowska-Łysiak K, Lauterbach R, Międzobrodzki J, Kosecka-Strojek M.
Pol J Microbiol. 2021 Mar;70(1):13-23. doi: 10.33073/pjm-2021-005. Epub 2021 Feb 24.
Coagulase-negative staphylococcus sepsis in preterm infants and long-term neurodevelopmental outcome.
Alshaikh B, Yee W, Lodha A, Henderson E, Yusuf K, Sauve R.
J Perinatol. 2014 Feb;34(2):125-9. doi: 10.1038/jp.2013.155. Epub 2013 Dec 19.
Staphylococcus epidermidis: a major player in bacterial sepsis?
Otto M.
Future Microbiol. 2017 Sep;12(12):1031-1033. doi: 10.2217/fmb-2017-0143. Epub 2017 Jul 27.
Genomic investigation of clinically significant coagulase-negative staphylococci.
Cole K, Atkins B, Llewelyn M, Paul J.
J Med Microbiol. 2021 Mar;70(3). doi: 10.1099/jmm.0.001337. Epub 2021 Mar 11.
Neonatal sepsis due to coagulase-negative staphylococci.
Marchant EA, Boyce GK, Sadarangani M, Lavoie PM.
Clin Dev Immunol. 2013;2013:586076. doi: 10.1155/2013/586076. Epub 2013 May 22.
Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don't want to ignore.
Babu E, Oropello J.
Expert Rev Anti Infect Ther. 2011 Oct;9(10):901-7. doi: 10.1586/eri.11.110.
Using population pharmacokinetics to optimize initial vancomycin dosing guidelines for neonates to treat sepsis caused by coagulase-negative staphylococcus.
Chung E, Seto W.
Pharmacotherapy. 2023 Dec;43(12):1262-1276. doi: 10.1002/phar.2865. Epub 2023 Aug 28.
Pathogenic conversion of coagulase-negative staphylococci.
Yu W, Kim HK, Rauch S, Schneewind O, Missiakas D.
Microbes Infect. 2017 Feb;19(2):101-109. doi: 10.1016/j.micinf.2016.12.002. Epub 2016 Dec 21.
[Coagulase-negative Staphylococcus bacteraemia].
Eiros JM, Carrero A, Carrero PA, León I.
Rev Esp Quimioter. 2013 Jun;26(2):166-7.
